Stay Informed, Stay Ahead: CVS’s Transition from Humira to Biosimilars
CVS Formulary Change – What You Need to Know CVS Caremark has announced the removal of Humira from some of their formularies starting the second quarter of 2024. The transition to biosimilar alternatives, which are part of the covered formulary, is planned. Key Points of the Announcement Impact Period: Starting April 1, 2024 Affected Parties: […]
Stay Informed, Stay Ahead: CVS’s Transition from Humira to Biosimilars Read More »
